Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Finasteride exposure harms tadpole reproduction and hormone balance.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Hormones and genes affect hair growth and male baldness.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Antiandrogen therapy helps treat genetic hair loss.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Menopause can cause skin issues, and seeing a dermatologist helps.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Possible link between androgens and COVID-19 severity; more research needed.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.